# Semaglutide, Other GLP-1 Receptor Agonists, and Papillary Thyroid Carcinoma: A Narrative Review of Risk, Progression, and Mechanisms

Review · Barseghyan L, Munir I, Chrysafide S, Simental A, Khan S

- Archive id: pmc:PMC13704980
- Published: 2026-10-01
- Venue: Journal of clinical medicine
- PMCID: PMC13704980
- Citations: 0
- Source URL: https://europepmc.org/article/PMC/PMC13704980
- PDF: https://europepmc.org/articles/PMC13704980/pdf
- Provenance: europepmc

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.